nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—Sirolimus—FGF2—periodontitis	0.157	1	CrCbGaD
Temsirolimus—MTOR—Leptin signaling pathway—IL1RN—periodontitis	0.0094	0.0112	CbGpPWpGaD
Temsirolimus—FKBP1A—TGF-beta Receptor Signaling—IFNG—periodontitis	0.00915	0.0109	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—IL1A—periodontitis	0.00837	0.00993	CbGpPWpGaD
Temsirolimus—CYP2D6—Melatonin metabolism and effects—ADRB1—periodontitis	0.00816	0.00967	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—IL4—periodontitis	0.0081	0.00961	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—IL18—periodontitis	0.00808	0.00958	CbGpPWpGaD
Temsirolimus—MTOR—Oncostatin M Signaling Pathway—MMP3—periodontitis	0.00803	0.00952	CbGpPWpGaD
Temsirolimus—MTOR—IL4-mediated signaling events—IL10—periodontitis	0.00784	0.00929	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—IL4—periodontitis	0.00783	0.00928	CbGpPWpGaD
Temsirolimus—MTOR—IL4-mediated signaling events—IL4—periodontitis	0.00762	0.00904	CbGpPWpGaD
Temsirolimus—MTOR—Type II diabetes mellitus—TNF—periodontitis	0.00683	0.0081	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—TLR4—periodontitis	0.00671	0.00796	CbGpPWpGaD
Temsirolimus—FKBP1A—TGF-beta receptor signaling—TGFB1—periodontitis	0.00654	0.00775	CbGpPWpGaD
Temsirolimus—CYP3A4—Aflatoxin activation and detoxification—GGT1—periodontitis	0.00649	0.00769	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—NTRK1—periodontitis	0.00648	0.00769	CbGpPWpGaD
Temsirolimus—MTOR—Oncostatin M Signaling Pathway—MMP1—periodontitis	0.00642	0.00761	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—NOS2—periodontitis	0.00638	0.00757	CbGpPWpGaD
Temsirolimus—FKBP1A—TGF-beta Receptor Signaling—TGFB1—periodontitis	0.00634	0.00752	CbGpPWpGaD
Temsirolimus—MTOR—IFN-gamma pathway—IFNG—periodontitis	0.00618	0.00732	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—NOS2—periodontitis	0.00617	0.00731	CbGpPWpGaD
Temsirolimus—MTOR—PI3K/AKT activation—NTRK1—periodontitis	0.00607	0.0072	CbGpPWpGaD
Temsirolimus—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—periodontitis	0.00602	0.00713	CbGpPWpGaD
Temsirolimus—FKBP1A—TGF-beta Receptor Signaling—TNF—periodontitis	0.00592	0.00702	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—CCL2—periodontitis	0.00576	0.00683	CbGpPWpGaD
Temsirolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—TGFB1—periodontitis	0.00571	0.00677	CbGpPWpGaD
Temsirolimus—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—periodontitis	0.00561	0.00665	CbGpPWpGaD
Temsirolimus—MTOR—IFN-gamma pathway—IL1B—periodontitis	0.00551	0.00653	CbGpPWpGaD
Temsirolimus—MTOR—Cardiac Hypertrophic Response—FGF2—periodontitis	0.00539	0.00639	CbGpPWpGaD
Temsirolimus—MTOR—TSLP Signaling Pathway—CXCL8—periodontitis	0.00535	0.00634	CbGpPWpGaD
Temsirolimus—MTOR—Oncostatin M Signaling Pathway—CCL2—periodontitis	0.00522	0.00619	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—IL1A—periodontitis	0.00517	0.00613	CbGpPWpGaD
Temsirolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—TGFB1—periodontitis	0.00515	0.00611	CbGpPWpGaD
Temsirolimus—MTOR—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—MET—periodontitis	0.00504	0.00598	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—IFNG—periodontitis	0.0049	0.00581	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—IFNG—periodontitis	0.00473	0.00561	CbGpPWpGaD
Temsirolimus—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—periodontitis	0.00473	0.00561	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—PTGS2—periodontitis	0.00469	0.00557	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—SLC52A3—periodontitis	0.00465	0.00551	CbGpPWpGaD
Temsirolimus—MTOR—BDNF signaling pathway—NTRK1—periodontitis	0.00457	0.00542	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—CXCL8—periodontitis	0.00455	0.0054	CbGpPWpGaD
Temsirolimus—MTOR—PI3K Cascade—FGF2—periodontitis	0.00455	0.00539	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL13—periodontitis	0.00444	0.00527	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—IL1B—periodontitis	0.00437	0.00518	CbGpPWpGaD
Temsirolimus—MTOR—Regulation of Telomerase—IFNG—periodontitis	0.00428	0.00508	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—IL1B—periodontitis	0.00422	0.005	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—MMP9—periodontitis	0.00412	0.00488	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL17A—periodontitis	0.00409	0.00485	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—CD79A—periodontitis	0.00384	0.00456	CbGpPWpGaD
Temsirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—FGF2—periodontitis	0.00384	0.00456	CbGpPWpGaD
Temsirolimus—MTOR—IRS-mediated signalling—FGF2—periodontitis	0.00381	0.00451	CbGpPWpGaD
Temsirolimus—MTOR—Constitutive PI3K/AKT Signaling in Cancer—FGF2—periodontitis	0.00377	0.00447	CbGpPWpGaD
Temsirolimus—MTOR—IRS-related events—FGF2—periodontitis	0.0037	0.00439	CbGpPWpGaD
Temsirolimus—MTOR—IRS-related events triggered by IGF1R—FGF2—periodontitis	0.00367	0.00435	CbGpPWpGaD
Temsirolimus—MTOR—IGF1R signaling cascade—FGF2—periodontitis	0.00357	0.00424	CbGpPWpGaD
Temsirolimus—MTOR—Insulin receptor signalling cascade—FGF2—periodontitis	0.00357	0.00424	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	0.00354	0.0042	CbGpPWpGaD
Temsirolimus—MTOR—Leptin signaling pathway—IL1B—periodontitis	0.00353	0.00419	CbGpPWpGaD
Temsirolimus—MTOR—Cardiac Hypertrophic Response—TGFB1—periodontitis	0.00352	0.00417	CbGpPWpGaD
Temsirolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—periodontitis	0.00346	0.0041	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—NTRK1—periodontitis	0.00343	0.00407	CbGpPWpGaD
Temsirolimus—MTOR—PI-3K cascade—FGF2—periodontitis	0.0034	0.00403	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—TGFB1—periodontitis	0.00339	0.00402	CbGpPWpGaD
Temsirolimus—MTOR—PI3K/AKT activation—FGF2—periodontitis	0.00331	0.00393	CbGpPWpGaD
Temsirolimus—CYP3A7—Biological oxidations—GGT1—periodontitis	0.00331	0.00393	CbGpPWpGaD
Temsirolimus—MTOR—GAB1 signalosome—FGF2—periodontitis	0.00329	0.0039	CbGpPWpGaD
Temsirolimus—MTOR—Cardiac Hypertrophic Response—TNF—periodontitis	0.00328	0.00389	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—MMP1—periodontitis	0.00327	0.00388	CbGpPWpGaD
Temsirolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—FGF2—periodontitis	0.00321	0.00381	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PTGS2—periodontitis	0.00319	0.00379	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CTSC—periodontitis	0.00317	0.00376	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—TNF—periodontitis	0.00317	0.00376	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—LTF—periodontitis	0.00316	0.00375	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—LBP—periodontitis	0.00313	0.00372	CbGpPWpGaD
Temsirolimus—MTOR—CXCR4-mediated signaling events—MMP9—periodontitis	0.00304	0.0036	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—IFNG—periodontitis	0.00302	0.00359	CbGpPWpGaD
Temsirolimus—MTOR—TSLP Signaling Pathway—IL6—periodontitis	0.003	0.00356	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by Insulin receptor—FGF2—periodontitis	0.00297	0.00352	CbGpPWpGaD
Temsirolimus—MTOR—Regulation of Telomerase—TGFB1—periodontitis	0.00297	0.00352	CbGpPWpGaD
Temsirolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—periodontitis	0.00291	0.00346	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—CXCL8—periodontitis	0.00281	0.00333	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL1A—periodontitis	0.0028	0.00331	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—FCGR3A—periodontitis	0.00279	0.00331	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL10—periodontitis	0.00278	0.0033	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—ACP5—periodontitis	0.00274	0.00325	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL4—periodontitis	0.0027	0.00321	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—IL1B—periodontitis	0.0027	0.0032	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—FCGR3A—periodontitis	0.00268	0.00318	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—NTRK1—periodontitis	0.00264	0.00313	CbGpPWpGaD
Temsirolimus—MTOR—Disease—SLC52A3—periodontitis	0.00261	0.0031	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—IL6—periodontitis	0.00256	0.00303	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—FGF2—periodontitis	0.00254	0.00301	CbGpPWpGaD
Temsirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—periodontitis	0.00251	0.00297	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—IL1A—periodontitis	0.00247	0.00293	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CXCL3—periodontitis	0.00247	0.00293	CbGpPWpGaD
Temsirolimus—ABCB1—HIF-1-alpha transcription factor network—NOS2—periodontitis	0.00246	0.00292	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—FGF2—periodontitis	0.00243	0.00288	CbGpPWpGaD
Temsirolimus—CYP3A5—Biological oxidations—GGT1—periodontitis	0.00239	0.00284	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—FGF2—periodontitis	0.00239	0.00283	CbGpPWpGaD
Temsirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TNF—periodontitis	0.00234	0.00277	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	0.00231	0.00274	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—FGF2—periodontitis	0.00228	0.00271	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—FGF2—periodontitis	0.00227	0.00269	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—FGF2—periodontitis	0.00226	0.00268	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—FGF2—periodontitis	0.00225	0.00267	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—FGF2—periodontitis	0.00222	0.00263	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CIITA—periodontitis	0.0022	0.00261	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	0.00216	0.00256	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—FCGR2A—periodontitis	0.00213	0.00253	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—FGF2—periodontitis	0.00212	0.00251	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—FGF2—periodontitis	0.00212	0.00251	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—FGF2—periodontitis	0.00212	0.00251	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—FGF2—periodontitis	0.0021	0.00249	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—TGFB1—periodontitis	0.0021	0.00249	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—FGF2—periodontitis	0.00208	0.00247	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—FGF2—periodontitis	0.00207	0.00245	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—MMP9—periodontitis	0.00201	0.00238	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—FGF2—periodontitis	0.00196	0.00232	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CTSC—periodontitis	0.00192	0.00228	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—FGF2—periodontitis	0.00187	0.00222	CbGpPWpGaD
Temsirolimus—MTOR—IRS-mediated signalling—IL6—periodontitis	0.00187	0.00222	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CCR2—periodontitis	0.00185	0.00219	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—LBP—periodontitis	0.00182	0.00216	CbGpPWpGaD
Temsirolimus—MTOR—IRS-related events—IL6—periodontitis	0.00182	0.00216	CbGpPWpGaD
Temsirolimus—MTOR—IRS-related events triggered by IGF1R—IL6—periodontitis	0.0018	0.00214	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—VIP—periodontitis	0.00178	0.00212	CbGpPWpGaD
Temsirolimus—MTOR—Disease—LTF—periodontitis	0.00178	0.00211	CbGpPWpGaD
Temsirolimus—MTOR—IGF1R signaling cascade—IL6—periodontitis	0.00176	0.00208	CbGpPWpGaD
Temsirolimus—MTOR—Insulin receptor signalling cascade—IL6—periodontitis	0.00176	0.00208	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—SLC52A3—periodontitis	0.00173	0.00205	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—TLR2—periodontitis	0.00172	0.00204	CbGpPWpGaD
Temsirolimus—CYP2D6—Biological oxidations—GGT1—periodontitis	0.0017	0.00202	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IFNG—periodontitis	0.00163	0.00194	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—FCGR3A—periodontitis	0.00163	0.00193	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CXCR2—periodontitis	0.00159	0.00189	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—IL6—periodontitis	0.00158	0.00187	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—periodontitis	0.00157	0.00186	CbGpPWpGaD
Temsirolimus—MTOR—VEGFA-VEGFR2 Pathway—IL6—periodontitis	0.00156	0.00184	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD79A—periodontitis	0.00155	0.00184	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CD14—periodontitis	0.00155	0.00183	CbGpPWpGaD
Temsirolimus—MTOR—Disease—ACP5—periodontitis	0.00154	0.00183	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—CXCL8—periodontitis	0.00152	0.0018	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by VEGF—IL6—periodontitis	0.00147	0.00174	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by Insulin receptor—IL6—periodontitis	0.00146	0.00173	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL1B—periodontitis	0.00146	0.00173	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—FGF2—periodontitis	0.00144	0.00171	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—VCAM1—periodontitis	0.00143	0.0017	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CXCL3—periodontitis	0.00139	0.00165	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—CXCL8—periodontitis	0.00134	0.00159	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—AGER—periodontitis	0.00127	0.0015	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—SLC52A3—periodontitis	0.00125	0.00148	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—IL6—periodontitis	0.00125	0.00148	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—FCGR2A—periodontitis	0.00124	0.00147	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCR2—periodontitis	0.00124	0.00147	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—ADRB1—periodontitis	0.00123	0.00146	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—IL6—periodontitis	0.00119	0.00142	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—IL6—periodontitis	0.00117	0.00139	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—TGFB1—periodontitis	0.00113	0.00134	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—IL6—periodontitis	0.00112	0.00133	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—IL6—periodontitis	0.00112	0.00132	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—GGT1—periodontitis	0.00111	0.00132	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—IL6—periodontitis	0.00111	0.00132	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CRP—periodontitis	0.00111	0.00131	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—IL6—periodontitis	0.00111	0.00131	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CCR2—periodontitis	0.00108	0.00128	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL1RN—periodontitis	0.00107	0.00127	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—TLR4—periodontitis	0.00106	0.00126	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—TNF—periodontitis	0.00106	0.00125	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—IL6—periodontitis	0.00104	0.00123	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—periodontitis	0.00104	0.00123	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—IL6—periodontitis	0.00104	0.00123	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—IL6—periodontitis	0.00103	0.00122	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—IL6—periodontitis	0.00102	0.00121	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ACP5—periodontitis	0.00102	0.00121	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—IL6—periodontitis	0.00102	0.00121	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NTRK1—periodontitis	0.00101	0.0012	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—VIP—periodontitis	0.001	0.00119	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—TLR2—periodontitis	0.001	0.00119	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—NOS2—periodontitis	0.000964	0.00114	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—SLC52A3—periodontitis	0.000943	0.00112	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD79A—periodontitis	0.00094	0.00111	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MMP3—periodontitis	0.000937	0.00111	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—periodontitis	0.000921	0.00109	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD14—periodontitis	0.000901	0.00107	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CXCR2—periodontitis	0.000894	0.00106	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—SLC52A3—periodontitis	0.000888	0.00105	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—VCAM1—periodontitis	0.00087	0.00103	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	0.000857	0.00102	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—FGF2—periodontitis	0.000822	0.000975	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—FGF2—periodontitis	0.00079	0.000936	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—FGF2—periodontitis	0.000786	0.000932	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—periodontitis	0.000773	0.000917	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL1A—periodontitis	0.000771	0.000914	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL18—periodontitis	0.000769	0.000912	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—IL6—periodontitis	0.000755	0.000896	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—AGER—periodontitis	0.000739	0.000876	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ACP5—periodontitis	0.000736	0.000873	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—PTGS2—periodontitis	0.000709	0.000841	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—IL6—periodontitis	0.000708	0.00084	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCR2—periodontitis	0.000695	0.000825	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ADRB1—periodontitis	0.000692	0.000821	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CRP—periodontitis	0.000644	0.000764	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—TLR4—periodontitis	0.000618	0.000732	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCL2—periodontitis	0.000609	0.000722	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SLC52A3—periodontitis	0.000581	0.000689	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NTRK1—periodontitis	0.000567	0.000672	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GGT1—periodontitis	0.000566	0.000672	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	0.000559	0.000663	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ACP5—periodontitis	0.000555	0.000659	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—FGF2—periodontitis	0.000551	0.000653	CbGpPWpGaD
Temsirolimus—MTOR—Disease—NOS2—periodontitis	0.000542	0.000643	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MMP3—periodontitis	0.000527	0.000625	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ACP5—periodontitis	0.000523	0.000621	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	0.000522	0.000619	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—TGFB1—periodontitis	0.000513	0.000608	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CXCL8—periodontitis	0.000482	0.000571	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—FGF2—periodontitis	0.000479	0.000568	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—PPARA—periodontitis	0.000472	0.00056	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IFNG—periodontitis	0.000451	0.000534	CbGpPWpGaD
Temsirolimus—MTOR—Disease—FGF2—periodontitis	0.000442	0.000524	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MMP9—periodontitis	0.000436	0.000517	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GGT1—periodontitis	0.000409	0.000486	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PPARA—periodontitis	0.000405	0.000481	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—IL6—periodontitis	0.000404	0.000479	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL1B—periodontitis	0.000402	0.000477	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PTGS2—periodontitis	0.000399	0.000473	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—IL6—periodontitis	0.000386	0.000458	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TGFB1—periodontitis	0.000359	0.000426	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCL2—periodontitis	0.000343	0.000406	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ACP5—periodontitis	0.000342	0.000406	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—FGF2—periodontitis	0.00031	0.000367	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GGT1—periodontitis	0.000309	0.000366	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PPARA—periodontitis	0.000293	0.000348	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GGT1—periodontitis	0.000291	0.000345	CbGpPWpGaD
Temsirolimus—MTOR—Disease—TGFB1—periodontitis	0.000288	0.000342	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CXCL8—periodontitis	0.000271	0.000321	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL6—periodontitis	0.000271	0.000321	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PTGS2—periodontitis	0.000264	0.000313	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MMP9—periodontitis	0.000245	0.000291	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL6—periodontitis	0.000235	0.000279	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PPARA—periodontitis	0.000221	0.000262	CbGpPWpGaD
Temsirolimus—MTOR—Disease—IL6—periodontitis	0.000217	0.000258	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PPARA—periodontitis	0.000208	0.000247	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TGFB1—periodontitis	0.000202	0.000239	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PTGS2—periodontitis	0.000191	0.000226	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GGT1—periodontitis	0.00019	0.000226	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL6—periodontitis	0.000152	0.00018	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PTGS2—periodontitis	0.000144	0.000171	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PPARA—periodontitis	0.000136	0.000162	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PTGS2—periodontitis	0.000135	0.000161	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PTGS2—periodontitis	8.86e-05	0.000105	CbGpPWpGaD
